Compounds > drospirenone
Page last updated: 2024-08-25

drospirenone and Arteriosclerosis

drospirenone has been researched along with Arteriosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabré, S; De Zegher, F; Ibáñez, L; Valls, C1
de Zegher, F; Ibáñez, L1

Trials

2 trial(s) available for drospirenone and Arteriosclerosis

ArticleYear
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:9

    Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins

2004
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:1

    Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors

2005